Trained immunity: A new avenue for tuberculosis vaccine development

Journal of Internal Medicine

Volumn 279, Issue 4, 2016, Pages 337-346

  Lerm, M ^a   Netea, M G ^b  

^a Division of Social Medicine and Public Health Science   (Sweden)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

BCG; Epigenetics; Innate immunity; Trained immunity; Tuberculosis

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; LEUKOTRIENE A4 HYDROLASE; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR 2; VITAMIN D RECEPTOR;

ADAPTIVE IMMUNITY; BCG VACCINATION; DNA METHYLATION; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; HISTONE MODIFICATION; HOST RESISTANCE; IMMUNOLOGICAL MEMORY; INNATE IMMUNITY; INTESTINE FLORA; LATENT TUBERCULOSIS; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE FUNCTION; MICROBIAL COLONIZATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; TARGET CELL; HUMAN; IMMUNOLOGY; PHYSIOLOGY; TUBERCULOSIS;

HUMANS; IMMUNITY, INNATE; LATENT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; RECEPTORS, PATTERN RECOGNITION; TUBERCULOSIS; TUBERCULOSIS VACCINES;

EID: 84961279345     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12449     Document Type: Review

References (72)

1. Ventura M, Canchaya C, Tauch A et al. Genomics of Actinobacteria: tracing the evolutionary history of an ancient phylum. Microbiol Mol Biol Rev 2007; 71: 495-548.
2. WHO. Global Tuberculosis Report. In WHO reports. Geneva, Switzerland: World Health Organization, 2012.
3. Schon T, Lerm M, Stendahl O. Shortening the 'short-course' therapy- insights into host immunity may contribute to new treatment strategies for tuberculosis. J Intern Med 2013; 273: 368-82.
4. Verrall AJ, Netea MG, Alisjahbana B, Hill PC, van Crevel R. Early clearance of Mycobacterium tuberculosis: a new frontier in prevention. Immunology 2014; 141: 506-13.
5. Meyer CG, Thye T. Host genetic studies in adult pulmonary tuberculosis. Semin Immunol 2014; 26: 445-53.
6. Vynnycky E, Fine PE. Interpreting the decline in tuberculosis: the role of secular trends in effective contact. Int J Epidemiol 1999; 28: 327-34.
7. Odone A, Houben RM, White RG, Lonnroth K. The effect of diabetes and undernutrition trends on reaching 2035 global tuberculosis targets. Lancet Diabetes Endocrinol 2014; 2: 754-64.
8. Netea MG, Quintin J, van der Meer JW. Trained immunity: a memory for innate host defense. Cell Host Microbe 2011; 9: 355-61.
9. Welin A, Lerm M. Inside or outside the phagosome? The controversy of the intracellular localization of Mycobacterium tuberculosis. Tuberculosis 2012; 92: 113-20.
10. Russell DG. Mycobacterium tuberculosis and the intimate discourse of a chronic infection. Immunol Rev 2011; 240: 252-68.
11. Welin A, Raffetseder J, Eklund D, Stendahl O, Lerm M. Importance of phagosomal functionality for growth restriction of mycobacterium tuberculosis in primary human macrophages. J Innate Immun 2011; 3: 508-18.
12. Abramovitch RB, Rohde KH, Hsu FF, Russell DG. aprABC: a Mycobacterium tuberculosis complex-specific locus that modulates pH-driven adaptation to the macrophage phagosome. Mol Microbiol 2011; 80: 678-94.
13. van der Wel N, Hava D, Houben D et al. M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells. Cell 2007; 129: 1287-98.
14. Houben D, Demangel C, van Ingen J et al. ESX-1-mediated translocation to the cytosol controls virulence of mycobacteria. Cell Microbiol 2012; 14: 1287-98.
15. Welin A, Eklund D, Stendahl O, Lerm M. Human macrophages infected with a high burden of ESAT-6-expressing M. tuberculosis undergo caspase-1- and cathepsin B-independent necrosis. PLoS One 2011; 6: e20302.
16. Davis JM, Ramakrishnan L. The role of the granuloma in expansion and dissemination of early tuberculous infection. Cell 2009; 136: 37-49.
17. Parasa VR, Rahman MJ, Ngyuen Hoang AT, Svensson M, Brighenti S, Lerm M. Modeling Mycobacterium tuberculosis early granuloma formation in experimental human lung tissue. Dis Model Mech 2013; 7: 281-8.
18. Rahman S, Gudetta B, Fink J et al. Compartmentalization of immune responses in human tuberculosis: few CD8+ effector T cells but elevated levels of FoxP3+ regulatory t cells in the granulomatous lesions. Am J Pathol 2009; 174: 2211-24.
19. Brighenti S, Andersson J. Local immune responses in human tuberculosis: learning from the site of infection. J Infect Dis 2012; 205(Suppl 2): S316-24.
20. Achkar JM, Chan J, Casadevall A. B cells and antibodies in the defense against Mycobacterium tuberculosis infection. Immunol Rev 2015; 264: 167-81.
21. Behar SM. Antigen-specific CD8(+) T cells and protective immunity to tuberculosis. Adv Exp Med Biol 2013; 783: 141-63.
22. Esin S, Batoni G. Natural killer cells: a coherent model for their functional role in Mycobacterium tuberculosis infection. J Innate Immun 2015; 7: 11-24.
23. Segovia-Juarez JL, Ganguli S, Kirschner D. Identifying control mechanisms of granuloma formation during M. tuberculosis infection using an agent-based model. J Theor Biol 2004; 231: 357-76.
24. Brill KJ, Li Q, Larkin R et al. Human natural killer cells mediate killing of intracellular Mycobacterium tuberculosis H37Rv via granule-independent mechanisms. Infect Immun 2001; 69: 1755-65.
25. Guirado E, Schlesinger LS. Modeling the mycobacterium tuberculosis granuloma - the critical battlefield in host immunity and disease. Front Immunol 2013; 4: 98.
26. Cohen HB, Mosser DM. Extrinsic and intrinsic control of macrophage inflammatory responses. J Leukoc Biol 2013; 94: 913-9.
27. Orme IM, Basaraba RJ. The formation of the granuloma in tuberculosis infection. Semin Immunol 2014; 26: 601-9.
28. Ehlers S, Benini J, Held HD, Roeck C, Alber G, Uhlig S. Alphabeta T cell receptor-positive cells and interferon-gamma, but not inducible nitric oxide synthase, are critical for granuloma necrosis in a mouse model of mycobacteria-induced pulmonary immunopathology. J Exp Med 2001; 194: 1847-59.
29. Comas I, Chakravartti J, Small PM et al. Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nat Genet 2010; 42: 498-503.
30. Houk VN, Baker JH, Sorensen K, Kent DC. The epidemiology of tuberculosis infection in a closed environment. Arch Environ Health 1968; 16: 26-35.
31. Fernando SL, Britton WJ. Genetic susceptibility to mycobacterial disease in humans. Immunol Cell Biol 2006; 84: 125-37.
32. Eklund D, Welin A, Andersson H et al. Human Gene Variants Linked to Enhanced NLRP3 Activity Limit Intramacrophage Growth of Mycobacterium tuberculosis. J Infect Dis 2013; 209: 749-53.
33. Tobin DM, Vary JC Jr, Ray JP et al. The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans. Cell 2010; 140: 717-30.
34. Areeshi MY, Mandal RK, Panda AK, Haque S. Vitamin D receptor ApaI gene polymorphism and tuberculosis susceptibility: a meta-analysis. Genet Test Mol Biomarkers 2014; 18: 323-9.
35. Kleinnijenhuis J, Quintin J, Preijers F et al. Long-lasting effects of BCG vaccination on both heterologous Th1/Th17 responses and innate trained immunity. J Innate Immun 2014; 6: 152-8.
36. Jiang H, Van De Ven C, Satwani P, Baxi LV, Cairo MS. Differential gene expression patterns by oligonucleotide microarray of basal versus lipopolysaccharide-activated monocytes from cord blood versus adult peripheral blood. J Immunol 2004; 172: 5870-9.
37. Kim SY, Romero R, Tarca AL et al. Methylome of fetal and maternal monocytes and macrophages at the feto-maternal interface. Am J Reprod Immunol 2012; 68: 8-27.
38. Brodin P, Jojic V, Gao T et al. Variation in the human immune system is largely driven by non-heritable influences. Cell 2015; 160: 37-47.
39. Abrahamsson TR, Jakobsson HE, Andersson AF, Bjorksten B, Engstrand L, Jenmalm MC. Low gut microbiota diversity in early infancy precedes asthma at school age. Clin Exp Allergy 2014; 44: 842-50.
40. Sjogren YM, Tomicic S, Lundberg A et al. Influence of early gut microbiota on the maturation of childhood mucosal and systemic immune responses. Clin Exp Allergy 2009; 39: 1842-51.
41. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009; 9: 313-23.
42. Cedar H, Bergman Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 2009; 10: 295-304.
43. Ronnerblad M, Andersson R, Olofsson T et al. Analysis of the DNA methylome and transcriptome in granulopoiesis reveals timed changes and dynamic enhancer methylation. Blood 2014; 123: e79-89.
44. Ost A, Lempradl A, Casas E et al. Paternal diet defines offspring chromatin state and intergenerational obesity. Cell 2014; 159: 1352-64.
45. Koonin EV. Calorie restriction a Lamarck. Cell 2014; 158: 237-8.
46. Muthamilarasan M, Prasad M. Plant innate immunity: an updated insight into defense mechanism. J Biosci 2013; 38: 433-49.
47. Pham LN, Dionne MS, Shirasu-Hiza M, Schneider DS. A specific primed immune response in Drosophila is dependent on phagocytes. PLoS Pathog 2007; 3: e26.
48. Roth O, Joop G, Eggert H et al. Paternally derived immune priming for offspring in the red flour beetle, Tribolium castaneum. J Anim Ecol 2010; 79: 403-13.
49. Hernandez Lopez J, Schuehly W, Crailsheim K, Riessberger-Galle U. Trans-generational immune priming in honeybees. Proc Biol Sci 2014; 281: 20140454.
50. Luna E, Ton J. The epigenetic machinery controlling transgenerational systemic acquired resistance. Plant Signal Behav 2012; 7: 615-8.
51. Luna E, Bruce TJ, Roberts MR, Flors V, Ton J. Next-generation systemic acquired resistance. Plant Physiol 2012; 158: 844-53.
52. Travassos LH, Carneiro LA, Ramjeet M et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol 2010; 11: 55-62.
53. Verma D, Sarndahl E, Andersson H et al. The Q705K polymorphism in NLRP3 is a gain-of-function alteration leading to excessive interleukin-1beta and IL-18 production. PLoS One 2012; 7: e34977.
54. Kleinnijenhuis J, Quintin J, Preijers F et al. Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci USA 2012; 109: 17537-42.
55. Kleinnijenhuis J, Quintin J, Preijers F et al. BCG-induced trained immunity in NK cells: Role for non-specific protection to infection. Clin Immunol 2014; 155: 213-9.
56. Quintin J, Saeed S, Martens JH et al. Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. Cell Host Microbe 2012; 12: 223-32.
57. Saeed S, Quintin J, Kerstens HH et al. Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity. Science 2014; 345: 1251086.
58. Cheng SC, Quintin J, Cramer RA et al. mTOR- and HIF-1alpha-mediated aerobic glycolysis as metabolic basis for trained immunity. Science 2014; 345: 1250684.
59. Ganguly N, Siddiqui I, Sharma P. Role of M. tuberculosis RD-1 region encoded secretory proteins in protective response and virulence. Tuberculosis 2008; 88: 510-7.
60. Roy A, Eisenhut M, Harris RJ et al. Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis. BMJ 2014; 349: g4643.
61. Tameris MD, Hatherill M, Landry BS et al. Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet 2013; 381: 1021-8.
62. Scriba TJ, Tameris M, Smit E et al. A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis-infected adults. Am J Respir Crit Care Med 2012; 185: 769-78.
63. Patel SY, Doffinger R, Barcenas-Morales G, Kumararatne DS. Genetically determined susceptibility to mycobacterial infection. J Clin Pathol 2008; 61: 1006-12.
64. Herbst S, Schaible UE, Schneider BE. Interferon gamma activated macrophages kill mycobacteria by nitric oxide induced apoptosis. PLoS One 2011; 6: e19105.
65. Martin-Fontecha A, Thomsen LL, Brett S et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 2004; 5: 1260-5.
66. Fenton MJ, Vermeulen MW, Kim S, Burdick M, Strieter RM, Kornfeld H. Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis. Infect Immun 1997; 65: 5149-56.
67. Kagina BM, Abel B, Scriba TJ et al. Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guerin vaccination of newborns. Am J Respir Crit Care Med 2010; 182: 1073-9.
68. Naeslund C. Expérience de vaccination par le BCG dans la province de Norrbotten (Suède). Revue de la Tuberculose 1931; 12: 617-36.
69. Garly ML, Martins CL, Bale C et al. BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa. A non-specific beneficial effect of BCG? Vaccine 2003; 21: 2782-90.
70. Lehmann D, Vail J, Firth MJ, de Klerk NH, Alpers MP. Benefits of routine immunizations on childhood survival in Tari, Southern Highlands Province, Papua New Guinea. Int J Epidemiol 2005; 34: 138-48.
71. Breiman RF, Streatfield PK, Phelan M, Shifa N, Rashid M, Yunus M. Effect of infant immunisation on childhood mortality in rural Bangladesh: analysis of health and demographic surveillance data. Lancet 2004; 364: 2204-11.
72. Moulton LH, Rahmathullah L, Halsey NA, Thulasiraj RD, Katz J, Tielsch JM. Evaluation of non-specific effects of infant immunizations on early infant mortality in a southern Indian population. Trop Med Int Health 2005; 10: 947-55.